Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dynorphin A immunoreactivity in human cerebrospinal fluid.

F Nyberg, I Nylander

    Regulatory Peptides
    |March 1, 1987
    PubMed
    Summary

    Researchers identified dynorphin A in human cerebrospinal fluid, finding most of it exists as larger precursor molecules rather than the active form. These larger forms contain the core Leu-enkephalin sequence.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    An intersectional analysis of sociodemographic disparities in Covid-19 vaccination: A nationwide register-based study in Sweden.

    Vaccine·2022
    Same author

    The Swedish National Airway Register (SNAR): development, design and utility to date.

    European clinical respiratory journal·2020
    Same author

    Higher self-reported severity of atopic dermatitis in adults is associated with poorer self-reported health-related quality of life in France, Germany, the U.K. and the U.S.A.

    The British journal of dermatology·2019
    Same author

    Increasing severity of atopic dermatitis is associated with a negative impact on work productivity among adults with atopic dermatitis in France, Germany, the U.K. and the U.S.A.

    The British journal of dermatology·2019
    Same author

    Developing classification criteria for skin-predominant dermatomyositis: the Delphi process.

    The British journal of dermatology·2019
    Same author

    S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).

    Journal of the European Academy of Dermatology and Venereology : JEADV·2016

    Area of Science:

    • Neuroscience
    • Biochemistry
    • Peptide Research

    Background:

    • Dynorphin A is a key opioid peptide involved in pain and mood regulation.
    • Characterization of dynorphin A in human cerebrospinal fluid (CSF) is crucial for understanding its physiological roles.
    • Previous studies have primarily focused on smaller, active forms of dynorphin peptides.

    Purpose of the Study:

    • To characterize the forms of dynorphin A immunoreactivity present in human cerebrospinal fluid.
    • To identify the molecular weights and structures of dynorphin A-related peptides in CSF.
    • To investigate the presence of the Leu-enkephalin-Arg6 sequence within these identified components.

    Main Methods:

    • Fractionation of large volumes of human CSF using Sephadex G-50 molecular sieving.
    • Analysis of fractions using radioimmunoassay (RIA) for dynorphin A.
    • High-performance liquid chromatography (HPLC) for further separation and analysis.
    • Enzyme radioimmunoassay (Enzyme-RIA) to specifically identify Leu-enkephalin-Arg6 sequences.

    Main Results:

    • Multiple dynorphin A-immunoreactive components of varying molecular sizes were detected in human CSF.
    • The majority of immunoreactive material consisted of higher molecular weight species (Mr 3000 and 5000) compared to authentic dynorphin A (Mr 2000).
    • The core Leu-enkephalin sequence was identified within both the larger (Mr 3000 and 5000) and smaller dynorphin A-related structures.

    Conclusions:

    • Human cerebrospinal fluid contains dynorphin A-related peptides primarily as larger precursor molecules.
    • These larger forms are processed and contain the Leu-enkephalin core, suggesting they are precursors to smaller active peptides.
    • Further research is needed to elucidate the specific roles and processing pathways of these high molecular weight dynorphin A forms in the central nervous system.

    Related Experiment Videos